Jeffrey Malehorn Acquires Shares in Sabra Health Care REIT

On June 17, 2026, insider Jeffrey Malehorn purchased 8,310 shares of Sabra Health Care REIT, Inc. (NasdaqGS: SBRA). At the time of the transaction, shares traded at $18.05 each.

Insider Buying and Selling at Sabra Health Care REIT, Inc.

Several insiders, including Jeffrey Malehorn, acquired 8,310 shares each of Sabra Health Care REIT on June 17, 2026. Other insiders involved in similar transactions were Ann Kono, Lynne Katzmann, Catherine Cusack, Michael Foster, and Craig Barbarosh. These purchases were not part of a pre-planned trading program.

Other Institutional Activity in Sabra Health Care REIT

BlackRock, Inc. increased its holdings by 704,770 shares, bringing its total to 39,098,389 shares valued at approximately $751.9 million. Principal Financial Group Inc added 98,770 shares, ending with 25,052,121 shares worth about $481.8 million. State Street Corp boosted its stake by 198,311 shares, holding 12,099,951 shares valued at $232.7 million. Meanwhile, JPMorgan Chase & Co made a significant addition of 5,569,621 shares, resulting in a total of 8,201,220 shares worth $159.4 million.

Sabra Health Care REIT Stock Snapshot

Shares of Sabra Health Care REIT, Inc. (NasdaqGS: SBRA) were trading near $18.05. The company has a market capitalization of approximately $4.57 billion and a P/E ratio of 28.76. It has a 52-week low of $17.17 and a high of $21.28. The 50-day moving average is $19.94, while the 200-day moving average is $19.31. Sabra's beta is 0.626, indicating lower volatility compared to the market.

Recent Earnings

Sabra Health Care REIT reported revenue of $815.7 million, with a growth rate of 21.7%. The company achieved a net margin of 19.15% and a return on equity of 5.68%. Earnings per share stood at $0.63. The next earnings report is scheduled for August 3, 2026.

Analysts Set New Price Targets

Analysts have maintained various ratings on Sabra Health Care REIT. On June 18, 2026, Scotiabank maintained a 'hold' rating with a $19.00 price target. Earlier, on June 1, 2026, Wells Fargo maintained a 'buy' rating with a $23.00 target. The consensus among 13 analysts is a 'buy' rating, with an average target price of $22.77.

About Sabra Health Care REIT, Inc.

Sabra Health Care REIT, Inc. is a real estate investment trust that owns and invests in healthcare-related properties across the United States and Canada. Headquartered in Tustin, California, the company operates under the leadership of CEO Richard K. Matros. With a workforce of 58 employees, Sabra focuses on providing real estate solutions for the healthcare industry.

Bottom Line

Jeffrey Malehorn's recent purchase of Sabra Health Care REIT shares is a noteworthy event for investors tracking insider activity. Sabra Health Care REIT's stock is backed by a solid market cap and analyst consensus ratings. As always, it's important to remember that insider trades are disclosed after they occur and may not reflect the current position.